Your session is about to expire
Ssri vs Snri List
Introduction
For patients dealing with major depressive disorder (MDD) or other types of depression and anxiety disorders, the family of drugs known as antidepressants can be instrumental in managing symptoms. These medications operate by altering the concentrations of certain neurotransmitters—chemicals involved in brain's communication—that are tied to mood. Two main categories include Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs). Examples from SSRI list could be Prozac (Fluoxetine), Zoloft (Sertraline), Celexa(Citalopram) among others which primarily increase levels of serotonin in the brain. On the SNRI list, we find medications such as Effexor(Venlafaxine), Cymbalta(Duloxetine) or Pristiq(Desvenlafaxine). These not only elevate serotonin but also norepinephrine levels, another key neurotransmitter involved in mood regulation.
Ssri vs Snri List Side By Side
| Attribute | Lexapro | Cymbalta |
|---|---|---|
| Brand Name | Lexapro | Cymbalta |
| Contraindications | Should not be taken with or have recently stopped using MAOIs. Increased risk of worsening depression or suicidal thoughts especially in individuals under 25. | Should not be taken with or have recently stopped using MAOIs. Increased risk of worsening depression or suicidal thoughts especially in individuals under 25. |
| Cost | $350 for 30 tablets of 10 mg | $240 for 30 capsules of 20 mg |
| Generic Name | Escitalopram | Duloxetine |
| Most Serious Side Effect | Increased thoughts about suicide or self-harm, Serotonin Syndrome | Liver damage, Serotonin Syndrome |
| Severe Drug Interactions | MAOIs, other SSRIs or SNRIs, certain pain medications, and drugs that affect serotonin levels. | MAOIs, other SSRIs or SNRIs, certain pain medications, and drugs that affect serotonin levels. |
| Typical Dose | Starts at lower doses around 20 mg/day for adults | Begins at a dose of 37.5-60 mg/day, can be increased to around 75-120 mg/day |
What is Ssri?
Selective serotonin reuptake inhibitors (SSRIs) and Serotonin and norepinephrine reuptake inhibitors (SNRIs) are two classes of antidepressant drugs, each with a unique list of medications. SSRIs work by selectively inhibiting the absorption of serotonin in the brain. The first SSRI drug, fluoxetine, was approved by the FDA in 1987. This marked a significant advancement over earlier types of antidepressants like tricyclic antidepressants (TCAs). Fluoxetine effectively "traps" free serotonin in the brain for an extended period.
On the other hand, SNRIs inhibit both serotonin and norepinephrine from being reabsorbed into your brain's neurons. Thus, these drugs have a broader influence on neurochemicals compared to SSRIs which may result in more side effects due to their effects on norepinephrine as well as serotonin.
Both types are prescribed for various forms of depression and anxiety disorders; however, some individuals respond better or experience fewer side effects with one class than another due to individual differences in neurotransmitter function and metabolism.
What conditions is Ssri approved to treat?
SSRIs (Selective Serotonin Reuptake Inhibitors) and SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors) are approved for the treatment of several mental health conditions, including:
- Major depressive disorder
- Generalized anxiety disorder
- Panic disorders
- Social anxiety disorder In certain cases, they may also be prescribed for other conditions such as obsessive-compulsive disorder, post-traumatic stress disorder, or fibromyalgia. Examples of SSRIs include Prozac (fluoxetine), Zoloft (sertraline), and Celexa (citalopram). Examples of SNRIs include Effexor (venlafaxine), Cymbalta(duloxetine), and Pristiq(desvenlafaxine).
How does Ssri help with these illnesses?
Selective serotonin reuptake inhibitors (SSRIs), like Prozac, work by increasing the amount of serotonin available in the synapses. They do this by blocking it from being reabsorbed by neurons so that levels can remain higher for longer periods of time. Serotonin is a neurotransmitter that plays an important role in mood regulation, cognition, memory, and numerous other functions.
Serotonin-norepinephrine reuptake inhibitors (SNRIs) on the other hand not only increase serotonin availability but also act upon another neurotransmitter called norepinephrine which is involved in regulating attention and response actions among others.
Both SSRIs and SNRIs have been found effective in treating depression but they differ slightly with respect to their side effects. The choice between them depends largely on individual patient factors including medical history, current health status and personal preferences.
What is Snri List?
SNRI stands for serotonin-norepinephrine reuptake inhibitors, a class of drugs that includes prestigious names like Venlafaxine (Effexor), Duloxetine (Cymbalta), and Desvenlafaxine (Pristiq). Unlike traditional SSRIs, which inhibit only the reuptake of serotonin in the brain, SNRIs also prevent norepinephrine's absorption. This dual action on two different neurotransmitters can potentially provide an advantage over SSRI medications by addressing a wider range of symptoms in certain conditions like depression and anxiety disorders.
These medications were first introduced to the market in 1993 with Venlafaxine being approved by FDA. Although they share some common side effects with SSRIs such as nausea, dry mouth and sexual dysfunction, their influence on norepinephrine might lead to additional side effects including increased heart rate or blood pressure. However, this unique mechanism of action may prove beneficial for patients who do not respond well to typical SSRI antidepressant drugs.
What conditions is Snri List approved to treat?
SNRI (Serotonin and Norepinephrine Reuptake Inhibitors) List includes medications that are approved for the treatment of conditions such as:
- Major depressive disorder (MDD)
- Generalized anxiety disorder (GAD)
- Panic disorder
- Social phobia
Some well-known SNRIs include Venlafaxine (Effexor), Duloxetine (Cymbalta), and Desvenlafaxine (Pristiq). They work by increasing levels of serotonin and norepinephrine in the brain, which can help improve mood, reduce anxiety, and alleviate chronic pain.
How does Snri List help with these illnesses?
Norepinephrine is a neurotransmitter that also acts as a hormone, playing roles in many body processes including wakefulness, memory recall, focus and attention. It's heavily involved in the "fight or flight" response to prepare the body for action under stress. As with serotonin, low levels of norepinephrine have been implicated in certain mental health conditions like depression. SNRI medications such as Effexor (venlafaxine), Cymbalta (duloxetine), and Pristiq (desvenlafaxine) work by increasing both serotonin and norepinephrine levels available in the brain thereby potentially providing more comprehensive symptom relief for patients than SSRIs. This dual-action can be beneficial when a patient does not respond adequately to typical SSRI antidepressants like Prozac or Zoloft. Therefore, SNRIs are sometimes considered when developing an individualized treatment plan especially where there has been insufficient improvement on an SSRI alone.
How effective are both Ssri and Snri List?
Both Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) have established histories of successfully treating patients with depression, anxiety disorders, and certain pain conditions. SSRIs were developed earlier than SNRIs, with the first SSRI, fluoxetine (Prozac), approved by the FDA in 1987. The first SNRI, venlafaxine (Effexor), was approved nearly a decade later in 1993.
Their mechanisms of action are different but related; both classes inhibit reuptake of serotonin to varying degrees while SNRIs also inhibit norepinephrine reuptake which may make them more effective for certain types of pain or particular patient populations. A direct comparison study between an SSRI (fluoxetine) and an SNRI (venlafaxine) showed similar efficacy in managing symptoms of depression as well as comparable safety profiles.
An extensive review published in 2007 indicated that SSRIs like fluoxetine demonstrated effectiveness from the first week of treatment onward, had generally lower side effects compared to older types antidepressants such as tricyclics or MAO inhibitors, and exhibited good tolerance even among elderly or pregnant populations. This has led to SSRIs becoming widely prescribed worldwide.
On the other hand, a meta-analysis conducted in 2018 suggested that while SNRIs might have slightly higher discontinuation rates due to adverse events compared with placebo or some SSRIs they still offered significant advantages over placebo for treating major depressive disorder and generalized anxiety disorder.
While both drug classes are considered first-line treatments for these conditions often times one class will be preferred over another based on individual patient characteristics such as comorbidity profile or prior response history to medications within each class.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Ssri typically prescribed?
Drugs from the SSRI group (Selective Serotonin Reuptake Inhibitors), such as Fluoxetine, Citalopram, and Sertraline typically start at lower doses around 20 mg/day for adults. This dose may be enough to treat depression in most people, but can be increased after some weeks if there is no response. For children and adolescents, doctors usually begin with a smaller dose. On the other hand, SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors) like Venlafaxine or Duloxetine also have variable starting dosages depending on the individual's condition and age; they are generally increased gradually under medical supervision until an effective dosage is reached. It's critical that maximum recommended doses are not exceeded for any of these medications without professional guidance.
At what dose is Snri List typically prescribed?
Typical treatment with an SNRI (Serotonin and Norepinephrine Reuptake Inhibitors) such as Venlafaxine or Duloxetine often begins at a dose of 37.5-60 mg/day. The dosage can then be increased to around 75-120 mg/day, divided into two doses, ideally spaced out over the day for even drug distribution in your system. If there is no significant response to the medication after several weeks, your healthcare provider might consider increasing the daily dose up to a maximum of about 225mg for Venlafaxine or 120mg for Duloxetine per day, split into two doses if necessary. As always, these medications should be taken under strict guidance from a medical professional who will adjust dosages based on individual patient needs and responses.
What are the most common side effects for Ssri?
When comparing Selective Serotonin Reuptake Inhibitors (SSRIs) to Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs), some common side effects may include:
- Anxiety or restlessness
- Nervousness, irritability
- Difficulty sleeping or insomnia
- Drowsiness or fatigue during the day
- General weakness
- Tremors or shaking hands
- Loss of appetite
- Nausea, vomiting, diarrhea
- Burning sensation in the stomach, or indigestion
- Dry mouth, excessive sweating
- Decreased sexual desire and other sexual dysfunction such as delayed ejaculation, inability to maintain an erection (impotence)
- Skin rashes, hives
-Vivid dreams or nightmares, -Influenza-like symptoms like fever, chills. muscle ache. -Inflammation of throat causing soreness and difficulty swallowing. -Sinusitis: inflammation of sinuses leading to headache. -Frequent yawning.
Please note that not everyone experiences all these side effects; they can vary from person to person based on their body's response to medication. It's important for patients starting new medications under these classes to monitor their bodies' reactions closely and report any adverse events promptly.
Are there any potential serious side effects for Ssri?
While both SSRI (Selective Serotonin Reuptake Inhibitors) and SNRI (Serotonin and Norepinephrine Reuptake Inhibitors) are widely used to treat depression, anxiety disorders, and certain other conditions, each group of medications comes with potential side effects that users should be aware of:
- Increased thoughts about suicide or self-harm: Both SSRI and SNRI can initially increase suicidal thoughts in some individuals, especially those under the age of 25.
- Allergic reactions or severe skin reactions: These might include hives; difficulty breathing; swelling in your face or throat; fever; sore throat; burning eyes; skin pain or a red/purple skin rash with blistering and peeling.
- Vision issues: Blurred vision, tunnel vision, eye pain/swelling, seeing halos around lights could occur due to changes in pupil dilation.
- Heart-related problems: Fast or pounding heartbeats/heart palpitations could occur as your body adjusts to the medication. This might also cause fluttering sensations in your chest, shortness of breath and sudden dizziness.
- Hyponatremia (low sodium levels): This condition is characterized by headaches/confusion/slurred speech/severe weakness/vomiting/loss of coordination/a feeling unsteadiness.
- Severe nervous system reaction - Very stiff muscles/high fever/sweating/confusion/fast or uneven heartbeats/tremors/a feeling you might pass out may indicate serotonin syndrome – a life-threatening reaction which requires immediate medical attention.
If any such symptoms arise after starting treatment with an SSRI/SNRI medication it is crucial to contact healthcare provider immediately.
What are the most common side effects for Snri List?
Serotonin and norepinephrine reuptake inhibitor (SNRI) medications, including the likes of Venlafaxine, Duloxetine, and Desvenlafaxine among others can cause several side effects:
- Dry mouth or excessive sweating
- Insomnia or sleep disturbances
- Blurry vision or dilated pupils
- Nausea, vomiting, stomach upset or a loss of appetite
- Constipation
- Increased heart rate causing palpitations
- Restlessness leading to anxiety or nervousness
- Tremors
- Reduced urination -Dizziness and headaches are also quite common. -Muscular stiffness resulting in joint pain.
It's important to note that some patients might experience skin reactions such as rashes. Weight fluctuations due to changes in metabolic rates could occur too. In rare cases confusion or agitation may develop; these symptoms should be reported immediately to your healthcare provider.
Are there any potential serious side effects for Snri List?
While SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors) are generally well-tolerated, they can occasionally cause severe side effects. These may include:
- Allergic reactions, such as skin rash, itching or hives; swelling of the face, lips or tongue
- Changes in blood pressure: high blood pressure can cause symptoms like severe headache, blurred vision, buzzing in your ears, anxiety and confusion; while low blood pressure might make you feel light-headed or faint.
- Mood changes like agitation, panic attacks or feeling nervous and restless
- Increased suicidal thoughts especially among young adults under 25 years old
- Vision problems such as blurred sight or eye pain
- Irregular heartbeat that you could notice as a racing heart rate
- Severe nausea, vomiting and diarrhea
Additionally, serotonin syndrome - characterized by agitation/restlessness/mania/hallucinations/rapid heartbeat/high fever/excessive sweating/muscle stiffness/twitching/seizures - is a serious condition that needs immediate medical attention. It's more likely to occur when starting an SNRI medication.
If any of these side effects appear while using an SNRI drug from the list (like Venlafaxine/Effexor), it's crucial to contact your healthcare provider immediately.
Contraindications for Ssri and Snri List?
Both SSRIs and SNRIs, along with most other antidepressant medications, may worsen symptoms of depression in some people. If you notice your depression worsening or an increase in suicidal ideation, thoughts or behavior while taking any medication from the SSRI list (including Fluoxetine/Prozac, Citalopram/Celexa etc.) or SNRI list (like Venlafaxine/Effexor, Duloxetine/Cymbalta etc.), please seek immediate medical attention.
Neither SSRIs nor SNRIs should be taken if you are using or have recently stopped using monoamine oxidase inhibitors (MAOIs). Always inform your healthcare provider about all medications that you're currently on; MAOIs will require a period of about 2 weeks to clear from the system to prevent dangerous interactions with both SSRIs and SNRIS. It's also crucial to observe a similar waiting period when switching between different types of antidepressants or even within the same class.
How much do Ssri and Snri List cost?
For the brand name versions of these drugs:
- The price of 30 tablets of a popular SSRI drug, Lexapro (10 mg), averages around $350, which works out to about $11.67/day.
- The price for 30 capsules of a widely used SNRI medication, Cymbalta (20 mg), is approximately $240 or about $8/day.
Thus, if you are in the higher dosage range for Lexapro (i.e., 20 mg/day), then brand-name Cymbalta tends to be less expensive on a per-day treatment basis. Please note that cost should not be a primary consideration in determining which class of antidepressants is right for you as both SSRIs and SNRIs have different effects and side-effect profiles.
As it goes with generic versions:
- Escitalopram (generic Lexapro) costs between $0.50 - $4 per day depending on your dose.
- Duloxetine (generic Cymbalta) is available at an approximate cost ranging from $1 - $5 per day based on dosage taken.
These costs may vary significantly based on pharmacy markups and insurance coverage. If paying out-of-pocket, buying larger quantities often reduces the unit-price and overall cost.
Popularity of Ssri and Snri List
Selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) are two main classes of antidepressants prescribed for the treatment of depression, anxiety disorders, and several other mood disorders.
In 2020, it was estimated that SSRIs were prescribed to approximately 30 million people in the US; they accounted for nearly 60% of all prescriptions for antidepressant medications. This class includes drugs like fluoxetine (Prozac), sertraline (Zoloft), citalopram (Celexa), escitalopram (Lexapro). The popularity of these medications has remained relatively stable over the last decade.
On the other hand, SNRIs were prescribed to about 7 million patients in the same period. These medications account for around 14% of all antidepressant prescriptions. Drugs from this class include venlafaxine (Effexor), desvenlafaxine (Pristiq), duloxetine(Cymbalta). As newer additions to the field, SNRI prescriptions have been generally increasing since their introduction.
Conclusion
Both Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) are widely prescribed for depression and anxiety disorders, with substantial clinical trials affirming their efficacy over placebo treatments. These two classes of drugs can sometimes be used in combination under the careful supervision of a physician due to potential contraindications between them. They function differently: SSRIs primarily act on serotonin while SNRIs affect both serotonin and norepinephrine neurotransmitter systems.
Typically, SSRIs are considered first-line treatment options due to their tolerability profile and effectiveness. Some examples include fluoxetine (Prozac), sertraline (Zoloft), and citalopram (Celexa). Conversely, SNRIs like venlafaxine (Effexor), duloxetine (Cymbalta), or desvenlafaxine (Pristiq) may be utilized as an adjunctive therapy to SSRI treatment or in patients who didn't respond well to first-line SSRI antidepressants.
Most drugs from these categories have generic forms available which means considerable cost savings for patients paying out of pocket. Patients should note that there might be an adjustment period with either class of medications where effects aren’t noticeable immediately.
The side effect profiles are generally similar among SSRIs and SNRis; they're typically well-tolerated but each has specific side effects associated more commonly with one class than the other - sexual dysfunction is often reported more frequently with SSRis, whereas increased blood pressure may occur more commonly with some SNRis. Importantly, all individuals starting any new antidepressant must monitor their moods closely during initial treatment phases; immediate medical help should be sought if mood worsens significantly or suicidal thoughts emerge.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Jakubovski, E., Johnson, J. A., Nasir, M., Müller-Vahl, K., & Bloch, M. H. (2018, November 26). Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders. Depression and Anxiety. Hindawi Limited.http://doi.org/10.1002/da.22854
- Jakubovski, E., Johnson, J. A., Nasir, M., Müller-Vahl, K., & Bloch, M. H. (2018, November 26). Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders. Depression and Anxiety. Hindawi Limited.http://doi.org/10.1002/da.22854
- Stahl, S. M., Grady, M. M., Moret, C., & Briley, M. (2005, September). SNRIs: The Pharmacology, Clinical Efficacy, and Tolerability in Comparison with Other Classes of Antidepressants. CNS Spectrums. Cambridge University Press (CUP).http://doi.org/10.1017/s1092852900019726
- Devane, C. L. (1995, October). Comparative safety and tolerability of selective serotonin reuptake inhibitors. Human Psychopharmacology: Clinical and Experimental. Wiley.http://doi.org/10.1002/hup.470100907
- Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018). Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review. Chonnam Medical Journal. Chonnam National University Medical School.http://doi.org/10.4068/cmj.2018.54.2.101
- Malone, D. C. (2007, July). A Budget-Impact and Cost-Effectiveness Model for Second-Line Treatment of Major Depression. Journal of Managed Care Pharmacy. Academy of Managed Care Pharmacy.http://doi.org/10.18553/jmcp.2007.13.s6-a.8
- Chen, Y., Kelton, C. M. L., Jing, Y., Guo, J. J., Li, X., & Patel, N. C. (2008, September). Utilization, price, and spending trends for antidepressants in the US Medicaid program. Research in Social and Administrative Pharmacy. Elsevier BV.http://doi.org/10.1016/j.sapharm.2007.06.019
- Masuka, J. T., Mchunu, N., Mkhize, Z., Thandar, Y., & Mosam, A. (2021, December 27). Selective serotonin reuptake inhibitor and serotonin‐norepinephrine reuptake inhibitor associated cutaneous adverse drug reactions: A systematic review of case reports and case series. Australasian Journal of Dermatology. Wiley.http://doi.org/10.1111/ajd.13780
- Zhong, Z., Wang, L., Wen, X., Liu, Y., Fan, Y., & Liu, Z. (2017, November). A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. Neuropsychiatric Disease and Treatment. Informa UK Limited.http://doi.org/10.2147/ndt.s141832
- Frampton, J. E., & Plosker, G. L. (2007). Duloxetine. CNS Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00023210-200721070-00004
- Nemeroff, C. B., & Owens, M. J. (2004). Pharmacologic Differences Among the SSRIs: Focus on Monoamine Transporters and the HPA Axis. CNS Spectrums. Cambridge University Press (CUP).http://doi.org/10.1017/s1092852900025475
- Baldwin, D. S. (2006, January). Serotonin noradrenaline reuptake inhibitors: A new generation of treatment for anxiety disorders. International Journal of Psychiatry in Clinical Practice. Informa UK Limited.http://doi.org/10.1080/13651500600637056
- Lisinski, A., Hieronymus, F., Eriksson, E., & Wallerstedt, S. M. (2021, January 22). Low SSRI dosing in clinical practice—a register‐based longitudinal study. Acta Psychiatrica Scandinavica. Wiley.http://doi.org/10.1111/acps.13275